Different O and K serotype distributions among clinical and environmental strains of serratia marcescens

Journal of Medical Microbiology

Volumn 47, Issue 12, 1998, Pages 1097-1104

  Aucken, Hazel M ^a   Pitt, T L ^a  

^a CENTRAL PUBLIC HEALTH LABORATORY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; O ANTIGEN;

ARTICLE; BACTERIAL MEMBRANE; ENVIRONMENTAL ASPECTS AND RELATED PHENOMENA; HOSPITAL INFECTION; NONHUMAN; PRIORITY JOURNAL; SEROTYPING; SERRATIA MARCESCENS;

EID: 0031757917     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/00222615-47-12-1097     Document Type: Article

References (27)

1. Grimont PAD, Grimont F, Starr MP. Serratia species isolated from plants. Curr Microbiol 1981; 5: 317-322.
2. Grimont PAD, Grimont F. The genus Serratia. In: Starr MP, Stolp H, Truper HG, Balows A, Schlegel HG (eds) The prokaryotes: a handbook on habitats, isolation and identification of bacteria, vol 2. Berlin, Springer-Verlag. 1981: 1187-1203.
3. Grimont PAD, Grimont F. The genus Serratia. Annu Rev Microbiol 1978; 32: 221-248.
4. Grimont PAD, Grimont F, Lysenko O. Species and biotype identification of Serratia strains associated with insects. Curr Microbiol 1979; 2: 139-142.
5. Pitt TL, Erdman YJ. Serological typing of Serratia marcescens. Methods Microbiol 1984; 15: 173-211.
6. Pitt TL, Erdman YJ, Bucher C. The epidemiological type identification of Serratia marcescens from outbreaks of infection in hospitals. J Hyg 1980; 84: 269-283.
7. Aucken HM, Wilkinson SG, Pitt TL. Identification of capsular antigens in Serratia marcescens. J Clin Microbiol 1997; 35: 59-63.
8. Aucken HM, Wilkinson SG, Pitt TL. Re-evaluation the serotypes of Serratia marcescens and separation into two schemes based on lipopolysaccharide (O) and capsular polysaccharide (K) antigens. Microbiology 1998; 144: 639-653.
9. King EO, Ward MK, Raney DF. Two simple media for the demonstration of pyocyanin and fluorescin. J Lab Clin Med 1954; 44: 301-307.
10. Farmer JJ, Davis BR, Hickman-Brenner FW et al. Biochemical identification of new species and biogroups of Enterobacteriaceae isolated from clinical specimens. J Clin Microbiol 1985; 21: 46-76.
11. Holmes B, Dawson CA, Pinning CA. A revised probability matrix for the identification of Gram-negative, aerobic, rod-shaped, fermentative bacteria. J Gen Microbiol 1986; 132: 3113-3135.
12. Aucken HM, Pitt TL. Lipopolysaccharide profile typing as a technique for the comparative typing of Gram-negative bacteria. J Clin Microbiol 1993; 31: 1286-1289.
13. Davis BR, Woodward JM. Some relationships of the somatic antigens of a group of Serratia marcescens cultures. Con J Microbiol 1957; 3: 591-597.
14. Ewing WH, Davis BR, Reavis RW. Studies on the Serratia group. Atlanta, CDC Publications, 1959.
15. Ewing WH, Johnson JG, Davis BR. The occurrence of Serratia marcescens in nosocomial infections. Atlanta, CDC Publications, 1962.
16. Sedlãk J, Dlabac V, Motlikovã M. The taxonomy of the Serratia genus. J Hyg Epidem 1965; 9: 45-53.
17. Wilfert JN, Barrett FF, Ewing WH, Finland M, Kass EH. Serratia marcescens: biochemical, serological and epidemiological characteristics and antibiotic susceptibility of strains isolated at Boston City Hospital. Appl Microbiol 1970; 19: 345-352.
18. Rubin SJ, Brock S, Chamberland M, Lyons RW. Combined serotyping and biotyping of Serratia marcescens. J Clin Microbiol 1976; 3: 582-585.
19. Anderhub B, Pitt TL, Erdman YJ, Willcox WR. A comparison of typing methods for Serratia marcescens. J Hyg 1977; 79: 89-102.
20. Le Minor S, Pigache F. [Antigenic study of "Serratia marcescens" isolated in France. II. Characterisation of O antigens and description of 5 new O factors, occurrence of serotypes and labelling of new H factors.] Étude antigénique de souches de Serratia marcescens. isolées en France. II. Caractérisation des antigénes O et individualisation de 5 nouveaux facteurs, fréquence de sérotypes et désignation des nouveaux facteurs H. Ann Microbiol 1978; 129B: 407-423.
21. Young VM, Moody MR, Morris MJ. Distribution of Serratia marcescens serotypes in cancer patients. J Med Microbiol 1980; 13: 333-339.
22. Gaston MA, Pitt TL. Improved O-serotyping method for Serratia marcescens. J Clin Microbiol 1989; 27: 2702-2705.
23. Gaston MA, Duff PS, Pitt TL. Lipopolysaccharide heterogeneity in strains of Serratia marcescens agglutinated by O14 antiserum. Curr Microbiol 1988; 17: 27-31.
24. Bale M, Sanford M, Hollis R, Pfaller MA. Application of a biotyping system and DNA restriction fragment analysis to the study of Serratia marcescens from hospitalized patients. Diagn Microbiol Infect Dis 1993; 16: 1-7.
25. Alonso R, Aucken HM, Perez-Diaz JC, Cookson BD, Baquero F, Pitt TL. Comparison of serotype, biotype and bacteriocin type with rDNA RFLP patterns for the type identification of Serratia marcescens.Epidemiol Infect 1993; 111: 99-107.
26. Traub WH, Eiden A, Leonhard B, Bauer D. Typing of nosocomial strains of Serratia marcescens: comparison of restriction enzyme cleaved genomic DNA fragment (PFGE) analysis with bacteriocin typing, biochemical profiles and serotyping. Zentralbl Bakteriol 1996; 284: 93-106.
27. Debast SB, Melchers WJG, Voss A, Hoogkamp-Korstanje JAA, Meis JFGM. Epidemitilogical survey of an outbreak of multiresistant Serratia marcescens by PCR-fingerprinting. Infection 1995; 23: 267-271.